AnGes, Inc. (4563.T)
JPY 50.0
(2.04%)
JPY 50.0
(2.04%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -11.96 Billion JPY | 26.66% |
| 2022 | -16.31 Billion JPY | -4.38% |
| 2021 | -15.63 Billion JPY | -179.17% |
| 2020 | -5.59 Billion JPY | -71.23% |
| 2019 | -3.27 Billion JPY | -6.68% |
| 2018 | -3.06 Billion JPY | 6.79% |
| 2017 | -3.28 Billion JPY | 30.96% |
| 2016 | -4.76 Billion JPY | -14.17% |
| 2015 | -4.17 Billion JPY | -83.47% |
| 2014 | -2.27 Billion JPY | -66.81% |
| 2013 | -1.36 Billion JPY | 23.65% |
| 2012 | -1.78 Billion JPY | 15.01% |
| 2011 | -2.1 Billion JPY | -4.5% |
| 2010 | -2.01 Billion JPY | 23.0% |
| 2009 | -2.61 Billion JPY | 2.75% |
| 2008 | -2.68 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -2.47 Billion JPY | 10.25% |
| 2024 Q2 | -2.63 Billion JPY | -6.24% |
| 2023 Q1 | -3.03 Billion JPY | 21.37% |
| 2023 Q4 | -2.75 Billion JPY | 15.27% |
| 2023 Q2 | -2.91 Billion JPY | 3.99% |
| 2023 FY | -11.96 Billion JPY | 26.66% |
| 2023 Q3 | -3.25 Billion JPY | -11.72% |
| 2022 Q2 | -5.58 Billion JPY | -57.5% |
| 2022 Q4 | -3.86 Billion JPY | -15.94% |
| 2022 Q1 | -3.54 Billion JPY | -2.16% |
| 2022 FY | -16.31 Billion JPY | -4.38% |
| 2022 Q3 | -3.33 Billion JPY | 40.32% |
| 2021 Q2 | -3.91 Billion JPY | -7.83% |
| 2021 Q4 | -3.46 Billion JPY | 24.96% |
| 2021 FY | -15.63 Billion JPY | -179.17% |
| 2021 Q3 | -4.62 Billion JPY | -18.15% |
| 2021 Q1 | -3.62 Billion JPY | -32.35% |
| 2020 Q4 | -2.74 Billion JPY | -151.12% |
| 2020 Q2 | -792.02 Million JPY | 18.7% |
| 2020 Q1 | -974.15 Million JPY | -6.88% |
| 2020 Q3 | -1.09 Billion JPY | -37.84% |
| 2020 FY | -5.59 Billion JPY | -71.23% |
| 2019 Q1 | -918.38 Million JPY | -11.58% |
| 2019 FY | -3.27 Billion JPY | -6.68% |
| 2019 Q3 | -648.98 Million JPY | 17.97% |
| 2019 Q2 | -791.19 Million JPY | 13.85% |
| 2019 Q4 | -911.44 Million JPY | -40.44% |
| 2018 Q2 | -615.19 Million JPY | -4.23% |
| 2018 Q1 | -590.25 Million JPY | -8.24% |
| 2018 Q3 | -1.03 Billion JPY | -68.52% |
| 2018 FY | -3.06 Billion JPY | 6.79% |
| 2018 Q4 | -823.07 Million JPY | 20.61% |
| 2017 Q2 | -666.97 Million JPY | 35.6% |
| 2017 FY | -3.28 Billion JPY | 30.96% |
| 2017 Q4 | -545.33 Million JPY | 47.6% |
| 2017 Q3 | -1.04 Billion JPY | -56.03% |
| 2017 Q1 | -1.03 Billion JPY | -3.3% |
| 2016 Q4 | -1 Billion JPY | -3.97% |
| 2016 Q3 | -964.31 Million JPY | 40.2% |
| 2016 Q2 | -1.61 Billion JPY | -36.21% |
| 2016 Q1 | -1.18 Billion JPY | -3.28% |
| 2016 FY | -4.76 Billion JPY | -14.17% |
| 2015 Q2 | -1.04 Billion JPY | -8.73% |
| 2015 FY | -4.17 Billion JPY | -83.47% |
| 2015 Q1 | -960.69 Million JPY | -326.45% |
| 2015 Q3 | -1.02 Billion JPY | 2.32% |
| 2015 Q4 | -1.14 Billion JPY | -12.34% |
| 2014 Q1 | -476.3 Million JPY | -14.23% |
| 2014 FY | -2.27 Billion JPY | -66.81% |
| 2014 Q2 | -559.57 Million JPY | -17.48% |
| 2014 Q4 | -225.27 Million JPY | 77.76% |
| 2014 Q3 | -1.01 Billion JPY | -80.98% |
| 2013 Q4 | -416.95 Million JPY | -33.12% |
| 2013 FY | -1.36 Billion JPY | 23.65% |
| 2013 Q3 | -313.21 Million JPY | -2.84% |
| 2013 Q2 | -304.56 Million JPY | 7.27% |
| 2013 Q1 | -328.42 Million JPY | 22.22% |
| 2012 Q2 | -442.09 Million JPY | 13.64% |
| 2012 Q4 | -422.23 Million JPY | -3.2% |
| 2012 Q3 | -409.14 Million JPY | 7.45% |
| 2012 FY | -1.78 Billion JPY | 15.01% |
| 2012 Q1 | -511.9 Million JPY | 15.85% |
| 2011 Q4 | -608.34 Million JPY | -41.87% |
| 2011 Q1 | -629.87 Million JPY | -15.94% |
| 2011 Q2 | -433.66 Million JPY | 31.15% |
| 2011 Q3 | -428.81 Million JPY | 1.12% |
| 2011 FY | -2.1 Billion JPY | -4.5% |
| 2010 Q1 | -507.67 Million JPY | 3.7% |
| 2010 Q2 | -495.77 Million JPY | 2.34% |
| 2010 Q4 | -543.26 Million JPY | -17.18% |
| 2010 Q3 | -463.6 Million JPY | 6.49% |
| 2010 FY | -2.01 Billion JPY | 23.0% |
| 2009 Q3 | -651.61 Million JPY | 0.7% |
| 2009 FY | -2.61 Billion JPY | 2.75% |
| 2009 Q2 | -656.18 Million JPY | 15.43% |
| 2009 Q4 | -527.16 Million JPY | 19.1% |
| 2009 Q1 | -775.92 Million JPY | 0.0% |
| 2008 FY | -2.68 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 2105.205% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -2308.588% |
| GNI Group Ltd. | 13.1 Billion JPY | 191.293% |
| Linical Co., Ltd. | 725.72 Million JPY | 1749.043% |
| Trans Genic Inc. | 89.43 Million JPY | 13481.081% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | -739.264% |
| Soiken Holdings Inc. | -610 Million JPY | -1861.863% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -1448.706% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | -967.765% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | -25.63% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 11574.227% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | -1284.463% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | -971.418% |
| CanBas Co., Ltd. | -1.26 Billion JPY | -848.297% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | -1398.639% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -3447.346% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | -893.015% |
| Kidswell Bio Corporation | -1.33 Billion JPY | -796.042% |
| PeptiDream Inc. | 6.77 Billion JPY | 276.693% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | -520.082% |
| Ribomic Inc. | -1.11 Billion JPY | -972.172% |
| SanBio Company Limited | -4.53 Billion JPY | -163.659% |
| Healios K.K. | -3.37 Billion JPY | -254.173% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | -936.077% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | -758.802% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | -752.994% |
| StemRIM | -2.07 Billion JPY | -476.469% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 1079.739% |
| FunPep Company Limited | -994 Million JPY | -1103.974% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -1246.536% |
| Stella Pharma Corporation | -760.3 Million JPY | -1474.05% |
| TMS Co., Ltd. | -943.25 Million JPY | -1168.748% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -1443.415% |
| Cuorips Inc. | -588.48 Million JPY | -1933.606% |
| K Pharma,Inc. | 366.05 Million JPY | 3369.301% |
| Takara Bio Inc. | 3 Billion JPY | 498.518% |
| ReproCELL Incorporated | -409.29 Million JPY | -2823.945% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 108275.938% |
| StemCell Institute Inc. | 413.75 Million JPY | 2992.385% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 8381.609% |
| CellSeed Inc. | -697.77 Million JPY | -1615.093% |